Company Quick10K Filing
Price28.90 EPS5
Shares33 P/E6
MCap954 P/FCF32
Net Debt157 EBIT190
TTM 2019-09-28, in MM, except price, ratios
10-Q 2020-09-26 Filed 2020-10-30
10-Q 2020-06-27 Filed 2020-08-04
10-Q 2020-03-28 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-03-02
10-Q 2019-09-28 Filed 2019-11-07
10-Q 2019-06-29 Filed 2019-08-08
10-Q 2019-03-30 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-29 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-07-01 Filed 2017-08-16
10-Q 2017-04-01 Filed 2017-05-05
10-K 2016-12-31 Filed 2017-02-24
10-Q 2016-10-01 Filed 2016-11-08
10-Q 2016-07-02 Filed 2016-08-04
10-Q 2016-04-02 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-24
10-Q 2015-10-03 Filed 2015-11-10
10-Q 2015-07-04 Filed 2015-08-11
10-Q 2015-04-04 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-27 Filed 2014-11-04
10-Q 2014-06-28 Filed 2014-08-05
10-Q 2014-03-29 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-07
10-Q 2013-09-28 Filed 2013-11-05
10-Q 2013-06-29 Filed 2013-08-06
10-Q 2013-03-30 Filed 2013-05-06
10-K 2012-12-31 Filed 2013-02-22
10-Q 2012-09-29 Filed 2012-11-07
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-04
10-K 2011-12-31 Filed 2012-03-07
10-Q 2011-10-01 Filed 2011-11-08
10-Q 2011-07-02 Filed 2011-08-09
10-Q 2011-04-02 Filed 2011-05-06
10-K 2010-12-31 Filed 2011-03-03
10-Q 2010-10-02 Filed 2010-11-08
10-Q 2010-07-03 Filed 2010-08-05
10-Q 2010-04-03 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-01
8-K 2021-02-23 Earnings, Exhibits
8-K 2020-10-30
8-K 2020-07-31
8-K 2020-05-21
8-K 2020-05-06
8-K 2020-05-04
8-K 2020-03-30
8-K 2020-02-26
8-K 2020-02-03
8-K 2019-12-09
8-K 2019-11-05
8-K 2019-10-04
8-K 2019-09-19
8-K 2019-08-05
8-K 2019-07-01
8-K 2019-06-10
8-K 2019-05-30
8-K 2019-05-08
8-K 2019-02-21
8-K 2019-02-13
8-K 2018-12-14
8-K 2018-11-13
8-K 2018-11-05
8-K 2018-09-21
8-K 2018-08-03
8-K 2018-06-13
8-K 2018-05-31
8-K 2018-05-09
8-K 2018-02-26
8-K 2018-02-16

ATRO 10Q Quarterly Report

Part I - Financial Information
Item 1. Financial Statements
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
Part II - Other Information
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
EX-31 atro20200926-10qxexh312.htm
EX-31.1 atro20200926-10qxexh311.htm
EX-32 atro20200929-10qxexh32.htm

Astronics Earnings 2020-09-26

Balance SheetIncome StatementCash Flow
Assets, Equity
Rev, G Profit, Net Income
Ops, Inv, Fin

Table of Contents

Washington, D.C. 20549
Form 10-Q
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 26, 2020
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from                      to                     
Commission File Number 0-7087
(Exact name of registrant as specified in its charter)

New York
(State or other jurisdiction of
incorporation or organization)
(IRS Employer
Identification Number)
130 Commerce Way, East Aurora, New York
(Address of principal executive offices)
(Zip code)
(716) 805-1599
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $.01 par value per shareATRONASDAQ Stock Market
(Former name, former address and former fiscal year, if changed since last report)

Table of Contents
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “large accelerated filer”, an “accelerated filer”, a “non-accelerated filer” and a “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
Accelerated filer
Emerging growth company
Non-accelerated filer
Smaller Reporting Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a)
of the Exchange Act. ¨
 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  ý
As of October 28, 2020, 30,800,663 shares of common stock were outstanding consisting of 23,927,431 shares of common stock ($.01 par value) and 6,873,232 shares of Class B common stock ($.01 par value).

Table of Contents
Item 1
Item 2
Item 3
Item 4
Item 1
Item 1a
Item 2
Item 3
Item 4
Item 5
Item 6


Table of Contents
Part I – Financial Information
Item 1. Financial Statements
Consolidated Condensed Balance Sheets
September 26, 2020 with Comparative Figures for December 31, 2019
(In thousands)
September 26, 2020December 31, 2019
Current Assets:
Cash and Cash Equivalents
$29,897 $31,906 
Accounts Receivable, Net of Allowance for Doubtful Accounts
92,947 147,998 
163,451 145,787 
Prepaid Expenses and Other Current Assets
27,375 15,853 
Assets Held for Sale 1,537 
Total Current Assets
313,670 343,081 
Property, Plant and Equipment, Net of Accumulated Depreciation108,111 112,499 
Operating Right-of-Use Assets19,802 23,602 
Other Assets23,341 31,271 
Intangible Assets, Net of Accumulated Amortization114,355 127,293 
Goodwill58,182 144,970 
Total Assets
$637,461 $782,716 
Current Liabilities:
Current Maturities of Long-term Debt
$232 $224 
Accounts Payable
26,320 35,842 
Current Operating Lease Liabilities4,969 4,517 
Accrued Expenses and Other Current Liabilities
42,831 48,697 
Customer Advance Payments and Deferred Revenue
24,916 31,360 
Total Current Liabilities
99,268 120,640 
Long-term Debt168,000 188,000 
Long-term Operating Lease Liabilities17,582 21,039 
Other Liabilities62,765 64,180 
Total Liabilities347,615 393,859 
Shareholders’ Equity:
Common Stock
346 345 
Accumulated Other Comprehensive Loss
Other Shareholders’ Equity
304,568 404,140 
Total Shareholders’ Equity
289,846 388,857 
Total Liabilities and Shareholders’ Equity$637,461 $782,716 
See notes to consolidated condensed financial statements.

Table of Contents
Consolidated Condensed Statements of Operations
Three and Nine Months Ended September 26, 2020 With Comparative Figures for 2019
(In thousands, except per share data)
Nine Months EndedThree Months Ended
September 26, 2020September 28, 2019September 26, 2020September 28, 2019
Sales$387,784 $574,290 $106,506 $177,018 
Cost of Products Sold310,059 445,056 91,333 140,224 
Gross Profit77,725 129,234 15,173 36,794 
Selling, General and Administrative Expenses85,941 90,677 24,170 31,691 
Impairment Loss87,016    
(Loss) Income from Operations(95,232)38,557 (8,997)5,103 
Net (Gain) Loss on Sale of Businesses (78,801) 1,332 
Other Expense, Net of Other Income4,546 1,197 369 464 
Interest Expense, Net of Interest Income5,091 4,576 1,775 1,547 
(Loss) Income Before Income Taxes(104,869)111,585 (11,141)1,760 
(Benefit from) Provision for Income Taxes(9,073)25,503 (5,887)550 
Net (Loss) Income$(95,796)$86,082 $(5,254)$1,210 
(Loss) Earnings Per Share:
$(3.11)$2.65 $(0.17)$0.04 
$(3.11)$2.61 $(0.17)$0.04 
See notes to consolidated condensed financial statements.

Table of Contents
Consolidated Condensed Statements of Comprehensive (Loss) Income
Three and Nine Months Ended September 26, 2020 With Comparative Figures for 2019
(In thousands)
Nine Months EndedThree Months Ended
September 26, 2020September 28, 2019September 26, 2020September 28, 2019
Net (Loss) Income$(95,796)$86,082 $(5,254)$1,210 
Other Comprehensive (Loss) Income:
Foreign Currency Translation Adjustments
(85)(722)1,409 (1,336)
Retirement Liability Adjustment – Net of Tax
645 441 215 147 
Total Other Comprehensive (Loss) Income560 (281)1,624 (1,189)
Comprehensive (Loss) Income$(95,236)$85,801 $(3,630)$21 
See notes to consolidated condensed financial statements.

Table of Contents
Consolidated Condensed Statements of Cash Flows
Nine Months Ended September 26, 2020 With Comparative Figures for 2019
(Unaudited, In thousands)
Nine Months Ended
Cash Flows from Operating Activities:September 26, 2020September 28, 2019
Net (Loss) Income$(95,796)$86,082 
Adjustments to Reconcile Net (Loss) Income to Cash Flows from Operating Activities, Excluding the Effects of Acquisitions/Divestitures:
Depreciation and Amortization24,095 24,183 
Provisions for Non-Cash Losses on Inventory and Receivables4,535 4,613 
Equity-based Compensation Expense3,924 2,943 
Deferred Tax Expense (Benefit)1,127 (3,820)
Non-cash Severance Expense3,007  
Operating Lease Amortization Expense3,352 2,993 
Non-cash Litigation Provision 1,700 
Net Gain on Sale of Businesses, Before Taxes (78,801)
Equity Investment Other Than Temporary Impairment3,493  
Impairment Loss87,016  
Other6,622 (5,485)
Cash Flows from Changes in Operating Assets and Liabilities:
Accounts Receivable53,604 23,423 
Accounts Payable(9,589)(5,494)
Accrued Expenses(11,340)(5,867)
Other Current Assets and Liabilities(224)(697)
Customer Advanced Payments and Deferred Revenue(6,474)(3,266)
Income Taxes(12,316)5,581 
Operating Lease Liabilities(3,412)(2,824)
Supplemental Retirement and Other Liabilities(304)3,940 
Cash Flows from Operating Activities31,513 30,241 
Cash Flows from Investing Activities:
Acquisition of Business, Net of Cash Acquired (21,785)
Proceeds on Sale of Business 104,792 
Capital Expenditures(5,575)(8,850)
Proceeds on Sale of Assets1,600  
Cash Flows from Investing Activities(3,975)74,157 
Cash Flows from Financing Activities:
Proceeds from Long-term Debt150,000 99,000 
Payments for Long-term Debt(170,000)(146,080)
Purchase of Outstanding Shares for Treasury(7,732)(50,000)
Stock Options Activity33 423 
Finance Lease Principal Payments(1,425)(1,284)
Financing Fees(360) 
Cash Flows from Financing Activities(29,484)(97,941)
Effect of Exchange Rates on Cash(63)(284)
(Decrease) Increase in Cash and Cash Equivalents(2,009)6,173 
Cash and Cash Equivalents at Beginning of Period31,906 16,622 
Cash and Cash Equivalents at End of Period$29,897 $22,795 
See notes to consolidated condensed financial statements.

Table of Contents
Consolidated Condensed Statements of Shareholders' Equity
Three and Nine Months Ended September 26, 2020 With Comparative Figures for 2019
(In thousands)

Nine Months EndedThree Months Ended
September 26, 2020September 28, 2019September 26, 2020September 28, 2019
Common Stock
Beginning of Period$269 $260 $274 $264 
Net Exercise of Stock Options— 1 —  
Class B Stock Converted to Common Stock8 4 3 1 
End of Period277 265 277 265 
Convertible Class B Stock
Beginning of Period76 83 72 80 
Net Exercise of Stock Options1 — — — 
Class B Stock Converted to Common Stock(8)(4)(3)(1)
End of Period69 79 69 79 
Additional Paid in Capital
Beginning of Period76,340 73,044 79,179 75,604 
Net Exercise of Stock Options and Equity-based Compensation Expense3,956 3,365 1,117 805 
End of Period80,296 76,409 80,296 76,409 
Accumulated Comprehensive Loss
Beginning of Period(15,628)(13,329)(16,692)(12,421)
Foreign Currency Translation Adjustments(85)(722)1,409 (1,336)
Retirement Liability Adjustment – Net of Taxes645 441 215 147 
End of Period(15,068)(13,610)(15,068)(13,610)
Retained Earnings
Beginning of Period428,584 376,567 338,042 461,439 
Net (Loss) Income(95,796)86,082 (5,254)1,210 
End of Period332,788 462,649 332,788 462,649 
Treasury Stock
Beginning of Period(100,784)(50,000)(108,516)(50,000)
Purchase of Shares(7,732)(50,000) (50,000)
End of Period(108,516)(100,000)(108,516)(100,000)
Total Shareholders’ Equity$289,846 $425,792 $289,846 $425,792 
See notes to consolidated condensed financial statements.


Table of Contents
Consolidated Condensed Statements of Shareholders' Equity, Continued
Three and Nine Months Ended September 26, 2020 With Comparative Figures for 2019
(In thousands)

Nine Months EndedThree Months Ended
September 26, 2020September 28, 2019September 26, 2020September 28, 2019
Common Stock
Beginning of Period26,874 25,978 27,355 26,343 
Net Issuance from Exercise of Stock Options69 53 44 19 
Class B Stock Converted to Common Stock790 444 334 113 
End of Period27,733 26,475 27,733 26,475 
Convertible Class B Stock
Beginning of Period7,650 8,290 7,209 8,007 
Net Issuance from Exercise of Stock Options16 50 1 2 
Class B Stock Converted to Common Stock(790)(444)(334)(113)
End of Period6,876 7,896 6,876 7,896 
Treasury Stock
Beginning of Period3,526 1,675 3,808 1,675 
Purchase of Shares282 1,823 — 1,823 
End of Period3,808 3,498 3,808 3,498 
See notes to consolidated condensed financial statements.


Table of Contents
Notes to Consolidated Condensed Financial Statements
September 26, 2020
1) Basis of Presentation
The accompanying unaudited statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation have been included.
Operating Results
The results of operations for any interim period are not necessarily indicative of results for the full year. In addition, the COVID-19 pandemic has increased the volatility we experience in our financial results in recent periods and this could continue in future interim and annual periods. Operating results for the nine months ended September 26, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.
The balance sheet at December 31, 2019 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements.
For further information, refer to the financial statements and footnotes thereto included in Astronics Corporation’s 2019 annual report on Form 10-K.
Description of the Business
Astronics Corporation (“Astronics” or the “Company”) is a leading provider of advanced technologies to the global aerospace, defense and electronics industries. Our products and services include advanced, high-performance electrical power generation, distribution and motion systems, lighting and safety systems, avionics products, systems and certification, aircraft structures and automated test systems.
We have principal operations in the United States (“U.S.”), Canada, France and England, as well as engineering offices in the Ukraine and India.
On February 13, 2019, the Company completed a divestiture of its semiconductor test business within the Test Systems segment. The business was not core to the future of the Test Systems segment. The total proceeds of the divestiture amounted to $103.8 million plus certain contingent purchase consideration (“earn-out”) as described in Note 18. The Company recorded a pre-tax gain on the sale of $80.1 million in the first quarter of 2019. The Company recorded income tax expense relating to the gain of $19.7 million.
On July 1, 2019, the Company acquired all of the issued and outstanding capital stock of Freedom Communication Technologies, Inc. (“Freedom”). Freedom, located in Kilgore, Texas, is a leader in wireless communication testing, primarily for the civil land mobile radio market. Freedom is included in our Test Systems segment. The total consideration for the transaction was $21.8 million, net of $0.6 million in cash acquired.
On July 12, 2019, the Company sold intellectual property and certain assets associated with its Airfield Lighting product line for $1.0 million in cash. The Airfield Lighting product line, part of the Aerospace segment, was not core to the business and represented less than 1% of revenue. The Company recorded a pre-tax loss on the sale of approximately $1.3 million in the third quarter of 2019.
On October 4, 2019, the Company acquired the stock of the primary operating subsidiaries as well as certain other assets from mass transit and defense market test solution provider, Diagnosys Test Systems Limited, for $7.0 million in cash, plus earn-outs estimated at a fair value of $2.5 million. Diagnosys Inc. and its affiliates (“Diagnosys”) is included in our Test Systems segment. Diagnosys is a developer and manufacturer of comprehensive automated test equipment providing test, support, and repair of high value electronics, electro-mechanical, pneumatic and printed circuit boards focused on the global mass transit and defense markets. The terms of the acquisition allow for a potential earn-out of up to an additional $13.0 million over the three years post-acquisition based on achievement of new order levels of over $72.0 million during that period. The acquired business has operations in Westford, Massachusetts as well as Ferndown, England, and an engineering center of excellence in Bangalore, India.

Table of Contents
For additional information regarding these acquisitions and divestitures see Note 18.
Impact of the COVID-19 Pandemic
On March 11, 2020, the World Health Organization classified the COVID-19 outbreak as a pandemic. The COVID-19 pandemic has had a sudden and significant impact on the global economy, and particularly in the aerospace industry, resulting in the grounding of the majority of the global commercial transportation fleet and significant cost cutting and cash preservation actions by the global airlines. This in turn has resulted in a significant reduction in airlines spending for both new aircraft and on upgrading their existing fleet with the Company’s products. We expect this low level of investment by the airlines will continue at least into 2021, however, the ultimate impact of COVID-19 on our business results of operations, financial condition and cash flows is dependent on future developments, including the duration of the pandemic and the related length of its impact on the global economy and the aerospace industry, which are uncertain and cannot be predicted at this time.
In response to the global COVID-19 pandemic, we have implemented actions to maintain our financial health and liquidity, as discussed in detail in our Form 8-K’s filed on March 31, 2020, May 6, 2020 and July 31, 2020. In addition to these measures, we amended our revolving credit facility on May 4, 2020, as further described in Note 7. We are also monitoring the impacts of COVID-19 on the fair value of assets. Refer to Note 6 for a discussion of goodwill impairment charges. Should future changes in sales, earnings and cash flows differ significantly from our expectations, long-lived assets to be held and used and goodwill could become impaired in the future.
Trade Accounts Receivable and Contract Assets
The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts. The Company regularly reviews the allowance by considering factors such as the age of the receivable balances, historical experience, credit quality, current economic conditions, and reasonable and supportable forecasts of future economic conditions that may affect a customer’s ability to pay. The allowance for doubtful accounts balance was $3.9 million and $3.6 million at September 26, 2020 and December 31, 2019, respectively. The Company’s bad debt expense was insignificant and $1.7 million in the three and nine months ended September 26, 2020, respectively, and insignificant in the three and nine months ended September 28, 2019. Total writeoffs charged against the allowance were $1.1 million and $1.2 million in the three month and nine months ended September 26, 2020, and insignificant in the three and nine months ended September 28, 2019. Total recoveries collected were insignificant in both the three and nine months ended September 26, 2020 and September 28, 2019.
The Company's exposure to credit losses may increase if its customers are adversely affected by global economic recessions, disruption associated with the current COVID-19 pandemic, industry conditions, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a material adverse impact from potential adjustments of the carrying amount of trade receivables and contract assets as airlines and other aerospace company’s cash flows are impacted by the COVID-19 pandemic.
Cost of Products Sold, Engineering and Development, Interest, and Selling, General and Administrative Expenses
Cost of products sold includes the costs to manufacture products such as direct materials and labor and manufacturing overhead as well as all engineering and development costs. The Company is engaged in a variety of engineering and design activities as well as basic research and development activities directed to the substantial improvement or new application of the Company’s existing technologies. These costs are expensed when incurred and included in cost of products sold. Research and development, design and related engineering amounted to $16.4 million and $25.6 million for the three months ended and $65.0 million and $80.0 million for the nine months ended September 26, 2020 and September 28, 2019, respectively. Selling, general and administrative expenses include costs primarily related to our sales and marketing departments and administrative departments. Interest expense is shown net of interest income. Interest income was insignificant for the three and nine months ended September 26, 2020 and September 28, 2019.
Goodwill Impairment
The Company tests goodwill at the reporting unit level on an annual basis or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.
As a result of the qualitative factors related to the COVID-19 pandemic, as discussed above, we performed interim quantitative assessments for the reporting units which had goodwill as of March 28, 2020, and an additional quantitative assessment for our PECO reporting unit as of June 27, 2020. Based on our quantitative assessments, the Company recorded goodwill impairment charges associated with four Aerospace reporting units, totaling $86.3 million within the Impairment Loss line in the Consolidated Condensed Statement of Operations in the nine months ended September 26, 2020. As of September 26, 2020, the

Table of Contents
Company concluded that no indicators of additional impairment relating to intangible assets or goodwill existed and an interim test was not performed in the three months then ended.
For additional information regarding the quantitative test and the related goodwill impairment see Note 6.
Valuation of Long-Lived Assets
Long-lived assets are evaluated for recoverability whenever adverse effects or changes in circumstances indicate that the carrying value may not be recoverable. The recoverability test consists of comparing the undiscounted projected cash flows with the carrying amount. Should the carrying amount exceed undiscounted projected cash flows, an impairment loss would be recognized to the extent the carrying amount exceeds fair value. In conjunction with the deteriorating economic conditions associated with the COVID-19 pandemic, we recorded an impairment charge to right-of-use (“ROU”) assets of approximately $0.7 million incurred in one reporting unit in the Aerospace segment within the Impairment Loss line in the Consolidated Condensed Statement of Operations in the nine months ended September 26, 2020. No other long-lived asset impairments were warranted based on the quantitative analysis performed.
Financial Instruments
The Company determined there were indicators of impairment over one of its investments in the second quarter of 2020 as a result of declining revenues and cash flows of the investee as well as significant uncertainties over the investee’s ability to raise additional capital or to finance its own activities. There were no observable price changes for this investment during 2020. We determined that the fair value of this investment was de minimus and we recorded an impairment charge of $3.5 million recorded within Other Expense, Net of Other Income in the accompanying Consolidated Condensed Statement Operations in the nine months ended September 26, 2020.
Foreign Currency Translation
The aggregate foreign currency transaction gain or loss included in operations was insignificant for the three and nine months ended September 26, 2020 and September 28, 2019.
Newly Adopted and Recent Accounting Pronouncements
Recent Accounting Pronouncements Adopted
StandardDescriptionFinancial Statement Effect or Other Significant Matters
ASU No. 2016-13
Financial Instruments - Credit Losses (Topic 326)
The standard replaces the incurred loss model with the current expected credit loss (CECL) model to estimate credit losses for financial assets measured at amortized cost and certain off-balance sheet credit exposures. The CECL model requires a Company to estimate credit losses expected over the life of the financial assets based on historical experience, current conditions and reasonable and supportable forecasts. The provisions of the standard are effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The amendment requires a modified retrospective approach by recording a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption.
The Company adopted this guidance as of January 1, 2020. The standard changed the way entities recognize impairment of most financial assets. Short-term and long-term financial assets, as defined by the standard, are impacted by immediate recognition of estimated credit losses in the financial statements, reflecting the net amount expected to be collected. The adoption of this standard had an immaterial impact on our condensed consolidated financial statements.

Date of adoption: Q1 2020
ASU No. 2018-13
Fair Value Measurement (Topic 820)
The standard removes the disclosure requirements for the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy. The provisions of this ASU are effective for years beginning after December 15, 2019, with early adoption permitted.
This ASU did not have a significant impact on our consolidated financial statements, as it only includes changes to disclosure requirements.
Date of adoption: Q1 2020

Table of Contents
Recent Accounting Pronouncements Not Yet Adopted
StandardDescriptionFinancial Statement Effect or Other Significant Matters
ASU No. 2018-14
Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20)
The standard includes updates to the disclosure requirements for defined benefit plans including several additions, deletions and modifications to the disclosure requirements. The provisions of this ASU are effective for years beginning after December 15, 2020, with early adoption permitted.
This ASU does not have a significant impact on our consolidated financial statements, as it only includes changes to disclosure requirements.
Planned date of adoption: Q1 2021
ASU No. 2019-12
Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes
The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and improve consistent application by clarifying and amending existing guidance. The amendments of this standard are effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period for which financial statements have not been issued, with the amendments to be applied on a respective, modified retrospective or prospective basis, depending on the specific amendment.
The Company is currently evaluating the requirements of this standard. The standard is not expected to have a material impact on the Company's financial statements.

Planned date of adoption: Q1 2021
ASU No. 2020-04
Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting
The amendments in Update 2020-04 are elective and apply to all entities that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. The new guidance provides the following optional expedients: simplify accounting analyses under current U.S. GAAP for contract modifications, simplify the assessment of hedge effectiveness, allow hedging relationships affected by reference rate reform to continue and allow a one-time election to sell or transfer debt securities classified as held to maturity that reference a rate affected by reference rate reform.
The amendments are effective for all entities from the beginning of an interim period that includes the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2022. After 2021, it is unclear whether banks will continue to provide LIBOR submissions to the administrator of LIBOR, and no consensus currently exists as to what benchmark rate or rates may become accepted alternatives to LIBOR. The Company is currently evaluating the impact of adopting this guidance.

Planned date of adoption: Before December 31, 2022
We consider the applicability and impact of all ASUs. ASUs not listed above were assessed and determined to be either not applicable, or had or are expected to have minimal impact on our financial statements and related disclosures.
2) Revenue
Revenue is recognized when, or as, the Company transfers control of promised products or services to a customer in an amount that reflects the consideration the Company expects to be entitled in exchange for transferring those products or services. Sales shown on the Company's Consolidated Condensed Statements of Operations are from contracts with customers.
Payment terms and conditions vary by contract, although terms generally include a requirement of payment within a range from 30 to 90 days after the performance obligation has been satisfied; or in certain cases, up-front deposits. In circumstances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that the Company's contracts generally do not include a significant financing component. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from sales.
The Company recognizes an asset for the incremental, material costs of obtaining a contract with a customer if the Company expects the benefit of those costs to be longer than one year and the costs are expected to be recovered. These incremental costs include, but are not limited to, sales commissions incurred to obtain a contract with a customer. As of September 26, 2020, the Company does not have material incremental costs on any open contracts with an original expected duration of greater than one year.

Table of Contents
The Company recognizes an asset for certain, material costs to fulfill a contract if it is determined that the costs relate directly to a contract or an anticipated contract that can be specifically identified, generate or enhance resources that will be used in satisfying performance obligations in the future, and are expected to be recovered. Such costs are amortized on a systematic basis that is consistent with the transfer to the customer of the goods to which the asset relates. Start-up costs are expensed as incurred. Capitalized fulfillment costs are included in Inventories in the accompanying Consolidated Condensed Balance Sheets. Should future orders not materialize or it is determined the costs are no longer probable of recovery, the capitalized costs are written off. As of September 26, 2020, the Company does not have material capitalized fulfillment costs.
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account. The majority of our contracts have a single performance obligation as the promise to transfer the individual goods or services is not separately identifiable from other promises in the contracts which are, therefore, not distinct. Thus, the contract's transaction price is the revenue recognized when or as that performance obligation is satisfied. Promised goods or services that are immaterial in the context of the contract are not separately assessed as performance obligations.
Some of our contracts have multiple performance obligations, most commonly due to the contract covering multiple phases of the product lifecycle (development, production, maintenance and support). For contracts with multiple performance obligations, the contract’s transaction price is allocated to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. The primary method used to estimate standalone selling price is the expected cost plus margin approach, under which expected costs are forecast to satisfy a performance obligation and then an appropriate margin is added for that distinct good or service. Shipping and handling activities that occur after the customer has obtained control of the good are considered fulfillment activities, not performance obligations.
Some of our contracts offer price discounts or free units after a specified volume has been purchased. The Company evaluates these options to determine whether they provide a material right to the customer, representing a separate performance obligation. If the option provides a material right to the customer, revenue is allocated to these rights and recognized when those future goods or services are transferred, or when the option expires.
Contract modifications are routine in the performance of our contracts. Contracts are often modified to account for changes in contract specifications or requirements. In most instances, contract modifications are for goods or services that are distinct, and, therefore, are accounted for as new contracts. The effect of modifications has been reflected when identifying the satisfied and unsatisfied performance obligations, determining the transaction price and allocating the transaction price.
The majority of the Company’s revenue from contracts with customers is recognized at a point in time, when the customer obtains control of the promised product, which is generally upon delivery and acceptance by the customer. These contracts may provide credits or incentives, which may be accounted for as variable consideration. Variable consideration is estimated at the most likely amount to predict the consideration to which the Company will be entitled, and only to the extent it is probable that a subsequent change in estimate will not result in a significant revenue reversal when estimating the amount of revenue to recognize. Variable consideration is treated as a change to the sales transaction price and based on an assessment of all information (i.e., historical, current and forecasted) that is reasonably available to the Company, and estimated at contract inception and updated at the end of each reporting period as additional information becomes available. Most of our contracts do not contain rights to return product; where this right does exist, it is evaluated as possible variable consideration.
For contracts that are subject to the requirement to accrue anticipated losses, the Company recognizes the entire anticipated loss in the period that the loss becomes probable.
For contracts with customers in which the Company promises to provide a product to the customer that has no alternative use to the Company and the Company has enforceable rights to payment for progress completed to date inclusive of profit, the Company satisfies the performance obligation and recognizes revenue over time, using costs incurred to date relative to total estimated costs at completion to measure progress toward satisfying our performance obligations. Incurred cost represents work performed, which corresponds with, and thereby best depicts, the transfer of control to the customer. Contract costs include labor, material and overhead.
The Company also recognizes revenue from service contracts (including service-type warranties) over time. The Company recognizes revenue over time during the term of the agreement as the customer is simultaneously receiving and consuming the benefits provided throughout the Company’s performance. The Company typically recognizes revenue on a straight-line basis throughout the contract period.
On September 26, 2020, we had $282.2 million of remaining performance obligations, which we refer to as total backlog. We expect to recognize approximately $115.5 million of our remaining performance obligations as revenue in 2020.

Table of Contents
Costs in excess of billings includes unbilled amounts resulting from revenues under contracts with customers that are satisfied over time and when the cost-to-cost measurement method of revenue recognition is utilized and revenue recognized exceeds the amount billed to the customer, and right to payment is not just subject to the passage of time. Amounts may not exceed their net realizable value. Costs in excess of billings are classified as current assets, within Accounts Receivable, Net of Allowance for Doubtful Accounts on our Consolidated Condensed Balance Sheet.
Billings in excess of cost includes billings in excess of revenue recognized as well as other elements of deferred revenue, which includes advanced payments, up-front payments, and progress billing payments. Billings in excess of cost are reported in our Consolidated Condensed Balance Sheet, classified as current liabilities, within Customer Advance Payments and Deferred Revenue, and non-current liabilities, within Other Liabilities. To determine the revenue recognized in the period from the beginning balance of billings in excess of cost, the contract liability as of the beginning of the period is recognized as revenue on a contract-by-contract basis when the Company satisfies the performance obligation related to the individual contract. Once the beginning contract liability balance for an individual contract has been fully recognized as revenue, any additional payments received in the period are recognized as revenue once the related costs have been incurred.
We recognized $8.5 million and $5.1 million during the three months ended and $20.1 million and $15.7 million for the nine months ended September 26, 2020 and September 28, 2019, respectively, in revenues that were included in the contract liability balance at the beginning of the period.
The Company's contract assets and contract liabilities consist primarily of costs and profits in excess of billings and billings in excess of cost and profits, respectively. The following table presents the beginning and ending balances of contract assets and contract liabilities during the nine months ended September 26, 2020:
(In thousands)Contract AssetsContract Liabilities
Beginning Balance, January 1, 2020$19,567 $38,758 
Ending Balance, September 26, 2020
$19,460 $29,392 
The following table presents our revenue disaggregated by Market Segments as follows:
Nine Months EndedThree Months Ended
(In thousands)September 26, 2020September 28, 2019September 26, 2020September 28, 2019
Aerospace Segment
Commercial Transport
$214,390 $393,721 $44,067 $122,212 
50,329 57,753 18,164 17,255 
Business Jet
45,259 49,555 14,711 12,432 
16,213 19,461 5,606 5,803 
Aerospace Total326,191 520,490 82,548 157,702 
Test Systems Segment
3,407 7,815 585 2,219 
Aerospace & Defense
58,186 45,985 23,373 17,097 
Test Systems Total61,593 53,800 23,958 19,316 
Total$387,784 $574,290 $106,506 $177,018 

Table of Contents
The following table presents our revenue disaggregated by Product Lines as follows:
Nine Months EndedThree Months Ended
(In thousands)September 26, 2020September 28, 2019September 26, 2020September 28, 2019
Aerospace Segment
Electrical Power & Motion
$148,500 $255,007 $32,481 $78,428 
Lighting & Safety
90,973 139,502 25,320 44,127 
57,381 79,414 16,104 19,871 
Systems Certification
5,596 9,050 605 3,384 
7,528 18,056 2,432 6,089 
16,213 19,461 5,606 5,803 
Aerospace Total326,191 520,490 82,548 157,702 
Test Systems61,593 53,800 23,958 19,316 
Total$387,784 $574,290 $106,506 $177,018 

3) Inventories
Inventories consisted of the following:
(In thousands)
September 26, 2020December 31, 2019
Finished Goods
$29,257 $33,434 
Work in Progress
26,911 25,594 
Raw Material
107,283 86,759 
$163,451 $145,787 
The Company has evaluated the carrying value of existing inventories and believe they are properly reflected at their lower of carrying value or net realizable value. Future changes in demand or other market developments could result in future inventory charges. The Company is actively managing inventories and aligning them to meet known current and future demand.
4) Property, Plant and Equipment
Property, Plant and Equipment consisted of the following:
(In thousands)
September 26, 2020December 31, 2019
$9,837 $9,802 
Buildings and Improvements
75,188 74,723 
Machinery and Equipment
119,688 115,202 
Construction in Progress
6,030 5,453 
210,743 205,180 
Less Accumulated Depreciation
102,632 92,681 
$108,111 $112,499 
Additionally, net Property, Plant and Equipment of $1.5 million are classified in Assets Held for Sale at December 31, 2019. Refer to Note 18.

Table of Contents
5) Intangible Assets
The following table summarizes acquired intangible assets as follows: 
September 26, 2020December 31, 2019
(In thousands)
Average Life
Gross Carrying
Gross Carrying
Patents11 years$2,146 $1,869 $2,146 $1,804 
Non-compete Agreement4 years11,091 9,627 11,318 7,696 
Trade Names10 years11,467 7,290 11,438 6,550 
Completed and Unpatented Technology9 years48,250 24,633 48,201 21,196 
Customer Relationships15 years142,528 57,708 142,212 50,776 
Total Intangible Assets12 years$215,482 $101,127 $215,315 $88,022 
All acquired intangible assets other than goodwill and one trade name are being amortized. Amortization expense for acquired intangibles is summarized as follows: 
Nine Months EndedThree Months Ended
(In thousands)
September 26, 2020September 28, 2019September 26, 2020September 28, 2019
Amortization Expense
$13,024 $